Radiesse in Kent: The Filler That Keeps Working Long After Treatment

Not all fillers do the same thing. And not all patients need the same kind of correction.

This is something I come back to repeatedly in consultations, the difference between a treatment that fills a space and a treatment that stimulates the body to rebuild what it has lost. It sounds like a subtle distinction.

Clinically, it isn't.

Radiesse is a calcium hydroxylapatite filler that sits firmly in the second category. It provides immediate volume in the same way a conventional filler does. But what distinguishes it from hyaluronic acid, the ingredient in almost every mainstream filler, is what happens after the initial correction is in place. Radiesse triggers the body's own collagen-producing machinery. The result lasts not just because the product is there, but because the tissue beneath it has been actively regenerated.

For the right patient, that distinction is the entire point.

What Radiesse actually is

Radiesse is composed of calcium hydroxylapatite microspheres, tiny spherical particles between 25 and 45 micrometres in diameter, suspended in a carboxymethylcellulose gel carrier. Calcium hydroxylapatite is not a synthetic compound. It is the same mineral that forms human bone and is found naturally in the body. It is the only calcium hydroxylapatite filler approved by the FDA for facial augmentation, and its biocompatibility is one of its defining clinical strengths.

When Radiesse is injected, the gel carrier provides immediate volumisation, visible correction from the moment of treatment. Over the following weeks, the gel is gradually reabsorbed by the body's macrophages and the CaHA microspheres are released into the surrounding tissue. This is where the biology becomes interesting.

The microspheres act as a scaffold. Fibroblasts, the cells responsible for producing collagen, attach to them, migrate around them, and are stimulated to produce new type I collagen fibres. In cardiac nursing, the principle I understood early was that the most durable clinical outcomes come from working with the body's repair mechanisms rather than substituting for them. Radiesse works on exactly that principle. A 2023 narrative review in Aesthetic Surgery Journal confirmed that compared directly to Juvéderm Voluma, Radiesse-treated patients showed significantly greater collagen I and elastin synthesis, with the CaHA microsphere-fibroblast interaction identified as the primary regenerative mechanism, not a secondary effect but the central biological process. Over time, the microspheres themselves degrade into calcium and phosphate ions and are eliminated through normal renal clearance. What remains is the tissue the body built in response to them.

Two modes: volumiser and biostimulator

Understanding Radiesse fully requires understanding that it functions in two distinct ways depending on how it's prepared. This is where much of the treatment's clinical versatility lies.

Radiesse used undiluted or lightly diluted: the volumiser

At standard concentration, Radiesse behaves as a structural filler. It provides immediate volumisation and contouring in areas requiring significant correction, the jawline, the cheeks, the chin, the nasolabial folds. The G prime of undiluted Radiesse is high, meaning it resists deformation and provides firm structural support. It is particularly well-suited to the lower face and areas where definition and projection are the clinical goal rather than simply hydration or quality improvement.

Results last 12 to 18 months, longer than most HA fillers in comparable areas, with histological evidence of ongoing collagen production beyond the period of visible correction.

Hyperdiluted Radiesse: the biostimulator

When Radiesse is diluted with saline, lidocaine, or a combination, in ratios from 1:1 up to 1:6, the behaviour changes fundamentally. The G prime drops, removing the immediate structural lift. What remains is the biostimulatory potential: the CaHA microspheres, now distributed across a much wider area of tissue, stimulating collagen, elastin, and angiogenesis in a diffuse, skin-quality-focused way.

This is the form of Radiesse I use for the neck, décolletage, and hands, places where the concern is skin quality, crepiness, and laxity rather than structural volume. A 50-patient case series published in PMC examining hyperdiluted Radiesse across the face, neck, décolletage, and hands found the treatment effective in improving skin thickness, laxity, and wrinkles in 95% of patients aged 30 to 40, 80% of those aged 40 to 60, and 70% of patients over 60, a meaningful response rate across a broad age range. Separately, a 2025 prospective study in PMC found dermal thickness increases of up to 210 micrometres at 90 days post-injection, a measurable structural improvement in the tissue itself, not just surface appearance.

Where Radiesse works

The treatment areas divide neatly along the two modes above.

For structural volumisation and contouring: the cheeks, the jawline, the chin, the temples, and the nasolabial folds. These are areas where immediate correction combined with sustained collagen stimulation produces results that are both visible from day one and genuinely long-lasting, not dependent on the product being present indefinitely but on the tissue that regenerates around it.

For hyperdiluted biostimulation: the neck and submental area, the décolletage, and the hands. These are the areas most commonly excluded from conventional aesthetics treatment planning. The patient who has invested in her face for years but whose neck and chest reveal her age at a glance is one I see regularly in clinic. The disconnect is real, it is common, and it is addressable.

HA fillers cannot cover this ground in the way Radiesse can. The neck and décolletage require treatment across a wide, thin, highly mobile area rather than the targeted structural placement conventional filler allows. Hyperdiluted Radiesse, delivered across the tissue in small microboluses or via a threading technique, distributes the biostimulatory effect evenly across exactly this kind of area. A 2019 expert consensus involving ten specialists formally established guidelines for hyperdiluted CaHA biostimulation across the face, neck, décolletage, and a range of body areas, confirming its clinical appropriateness in areas where HA filler simply is not the right tool.

How Radiesse compares to hyaluronic acid filler

This is the question I'm most frequently asked, and the answer requires being specific rather than categorical.

HA fillers, Profhilo, Juvederm, Restylane, Stylage, are hydrophilic. They attract and retain water in tissue. They provide volume through hydration, stimulate some collagen production through mechanical tension on fibroblasts, and are reversible with hyaluronidase. Their primary strength is versatility and reversibility.

Radiesse's primary strength is longevity and biostimulatory depth. The CaHA microsphere-fibroblast interaction drives significantly more collagen and elastin synthesis than HA alone, a directly observed histological difference rather than a qualitative claim. For patients who want a treatment that produces lasting structural tissue improvement rather than simply filling a space that will gradually empty again, this distinction matters.

The critical difference patients must understand: Radiesse is not reversible. There is no equivalent of hyaluronidase for CaHA. The microspheres degrade naturally over time, but if the result is wrong, there is no enzymatic correction available. This places the clinical responsibility for correct placement and appropriate candidacy assessment squarely on the practitioner. It is one reason I approach Radiesse candidacy and technique with particular care and why I consider it a different level of clinical decision from HA filler. Not a reason to avoid it. A reason to choose your practitioner carefully.

The areas most patients overlook, and why Radiesse addresses them better than anything else

There is a specific clinical gap that Radiesse fills better than any other injectable treatment I use.

The neck and décolletage age in parallel with the face, often faster, because they receive cumulative UV exposure across a lifetime while being largely excluded from the protective skincare routines people apply to their faces. The skin becomes thinner, more crepey, less defined. Lines appear. The texture changes in a way that makes age apparent regardless of how well-maintained the face above it is.

This is also directly relevant for patients on GLP-1 medications, Mounjaro, Wegovy, Ozempic, where the rapid reduction in subcutaneous fat affects the neck and chest as much as the face. The Ozempic face post covers the facial dimension in detail. The body equivalent, crepey, lax skin across the neck and décolletage following significant weight loss, is a clinical problem that hyperdiluted Radiesse addresses directly and effectively.

For patients considering dermal fillers and wanting to understand where Radiesse sits in that landscape, or those approaching it as part of a broader longevity medicine and regenerative skin strategy, the neck and décolletage question is often where the clinical case for Radiesse becomes most compelling.

What a Radiesse consultation at Juvenology looks like

I assess Radiesse candidacy carefully and honestly. Because the treatment is not reversible, the consultation is where the most important clinical decisions are made.

I look at what you're trying to address, volume, definition, quality, laxity, and where. I look at your medical history, including any history of autoimmune conditions, keloid scarring, or prior reactions to injectable treatments. I look at your expectations and whether they are calibrated appropriately for what a biostimulator can and cannot achieve.

I also consider your broader biological picture. Patients whose skin quality decline is significantly driven by hormonal factors, as is the case for many women in perimenopause and beyond where oestrogen withdrawal directly accelerates collagen loss, may find that addressing the systemic driver through our Advanced Blood Panel and Longevity Medicine consultation improves the response to any biostimulatory treatment, including Radiesse. The biology the treatment is trying to stimulate needs to be in a position to respond. That assessment is part of what makes a consultation here different from most.

For patients also having polynucleotides or Profhilo, Radiesse can be sequenced alongside these treatments, each working through a different mechanism but contributing to a cumulative improvement in skin architecture that none achieves alone. The sequencing matters and it is planned at the consultation rather than left to chance.

Who Radiesse suits, and who it doesn't

Radiesse is most appropriate for patients with mild to moderate skin laxity and volume loss seeking a longer-lasting result than HA filler provides, patients with neck and décolletage concerns that HA filler cannot address effectively, and patients who understand and accept the non-reversible nature of the treatment.

It is not appropriate for patients who may need the result corrected, patients with uncertain expectations, or patients who are not clearly suitable on the basis of medical history and candidacy assessment. It is not recommended in high-risk vascular areas without very specific technique considerations and a high level of practitioner experience.

The honest version of this candidacy assessment is what you'll receive at Juvenology. Not a consultation designed to confirm the treatment you arrived expecting. A genuine clinical evaluation of whether Radiesse is the right tool for your specific concern.

Radiesse represents what I value most in aesthetic medicine: a treatment that works with the body's own biology rather than substituting for it. The collagen it stimulates is yours. The elastin is yours. What the treatment does is give your fibroblasts the signal they've stopped receiving on their own. That is regenerative aesthetics done properly.

To discuss whether Radiesse is appropriate for your specific concern, book a consultation at Juvenology.

We see patients from across Kent including Maidstone, Tonbridge, Sevenoaks, Kings Hill, West Malling, Medway, and Chatham.

About the author

Nurse Marina is the founder of Juvenology Clinic in Maidstone, Kent.

She spent 25 years in nursing, including six years as a cardiac nurse at KIMS Hospital, before founding Juvenology to combine regenerative aesthetic medicine with longevity science.

She holds an Executive MSc in Longevity from the Geneva College of Longevity Science, has completed the Healthy Longevity Clinician Programme at the National University of Singapore, and holds qualifications in hormonal health from the Marion Gluck Academy.

She is NMC Registered, JCCP Verified, BACN Member, ACE Group Registered, a Member of the Royal College of Nursing, and recognised by the Professional Standards Authority.

Book a consultation at Juvenology

Clinical references

The Role of Calcium Hydroxylapatite (Radiesse) as a Regenerative Aesthetic Treatment: A Narrative Review — Aesthetic Surgery Journal / Oxford Academic, 2023 academic.oup.com/asj/article/43/10/1063/7249933

Skin Regeneration-Related Mechanisms of Calcium Hydroxylapatite (CaHA): A Systematic Review — Frontiers in Medicine / PMC, 2023 ncbi.nlm.nih.gov/pmc/articles/PMC10273839/

Starting Point for Protocols on the Use of Hyperdiluted Radiesse for Face, Neck, Décolletage and Hands: A Case Series — PMC, 2023 pmc.ncbi.nlm.nih.gov/articles/PMC10693750/

Consensus Recommendations for the Use of Hyperdiluted Calcium Hydroxyapatite as a Face and Body Biostimulatory Agent — PMC, 2019 pmc.ncbi.nlm.nih.gov/articles/PMC6467620/

Calcium Hydroxylapatite-Based Fillers in Facial Rejuvenation: Prospective Comparative Outcome Study — PMC, 2025 pmc.ncbi.nlm.nih.gov/articles/PMC12193805/